Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-05-18

Clinical Trial Update: Hemodynamic Response of Neuropathic And Non-Neuropathic POTS Patients To Adrenoreceptor Agonist And Antagonist [Phase 1, Phase 2]

View source ↗

Summary

The Beth Israel Deaconess Medical Center study evaluated hemodynamic responses in neuropathic and non-neuropathic POTS patients to an adrenoreceptor agonist and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Adrenoreceptor agonist
  • Adrenoreceptor antagonist

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: Postural Orthostatic Tachycardia Syndrome, Orthostatic Intolerance | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2017-05-18